David Shaw’s Sanofi SNY Stock Holding History

David Shaw’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-5,000	Closed	-$282K	–	4232
2014 Q3	$282K	Hold	5,000	–	–	﹤0.01%	3723
2014 Q2	$266K	Hold	5,000	–	–	﹤0.01%	3875
2014 Q1	$261K	Hold	5,000	–	–	﹤0.01%	3973
2013 Q4	$268K	Sell	5,000 -62,200	-93%	-$3.21M	﹤0.01%	4117
2013 Q3	$3.4M	Buy	67,200 +30,200	+82%	+$1.54M	0.01%	1952
2013 Q2	$1.91M	Buy	+37,000	New	+$1.97M	﹤0.01%	2155

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.8B AUM 25.03% 1-Year Est. Return

David Shaw's SNY Position: Q4 2014 in Review

David Shaw sold out of Sanofi (SNY) in Q4 2014, closing a stake of 5,000 shares — an estimated $282K sold.

David Shaw first reported a position in SNY in Q2 2013 and held it in 6 quarters. The position peaked at $3.4M in Q3 2013. 499 funds tracked by Wall St. Rank hold SNY as of Q4 2014.

David Shaw reported no remaining Sanofi position as of Q4 2014 after selling out during the quarter.
David Shaw sold 5,000 Sanofi shares in Q4 2014, an estimated $282K.
David Shaw first reported a position in Sanofi in Q2 2013 and held it in 6 quarters.
David Shaw's Sanofi position peaked at $3.4M in Q3 2013.
499 funds tracked by Wall St. Rank held Sanofi as of Q4 2014.

Based on D.E. Shaw & Co's 13F filing for Q4 2014, filed 17 Feb 2015.